The implication of combat y stress and PTSD trajectories y in Metabolic syndrome and elevated C-reactive protein levels: A longitudinal study

Journal of Clinical Psychiatry

Volumn 78, Issue 9, 2017, Pages e1180-e1186

  Solomon, Zahava ^a   Levin, Yafit ^a   Assayag, Einor Ben ^b   Furman, Orit ^c,d   Shenhar Tsarfaty, Shani ^b   Berliner, Shlomo ^a,b   Ohry, Avi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DSM-IV-TR; EARLY DIAGNOSIS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH HAZARD; HEMATOCRIT; HUMAN; HYPERTENSION; INJURY; INSULIN BLOOD LEVEL; ISRAELI; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENTAL STRESS; METABOLIC SYNDROME X; NEUTROPHIL COUNT; OBESITY; PHYSIOLOGICAL STRESS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PRISONER OF WAR; PROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; BLOOD; COMPLICATION; ISRAEL; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; TIME FACTOR; VETERAN;

C-REACTIVE PROTEIN; COMBAT DISORDERS; HUMANS; ISRAEL; LONGITUDINAL STUDIES; METABOLIC SYNDROME; PRISONERS OF WAR; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; STRESS DISORDERS, POST-TRAUMATIC; TIME FACTORS; VETERANS;

EID: 85038034727     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.16m11344     Document Type: Article

References (76)

1. Yehuda R, LeDoux J. Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron. 2007;56(1):19–32.
2. Boscarino JA, Chang J. Higher abnormal leukocyte and lymphocyte counts 20 years after exposure to severe stress: research and clinical implications. Psychosom Med. 1999;61(3):378–386.
3. Gill JM, Saligan L, Woods S, et al. PTSD is associated with an excess of inflammatory immune activities. PerspectPsychiatrCare. 2009;45(4):262–277.
4. O’Donovan A, Chao LL, Paulson J, et al. Altered inflammatory activity associated with reduced hippocampal volume and more severe posttraumatic stress symptoms in Gulf War veterans. Psychoneuroendocrinology. 2015;51:557–566.
5. Edmondson D, Cohen BE. Posttraumatic stress disorder and cardiovascular disease. Prog Cardiovasc Dis. 2013;55(6):548–556.
6. Levine AB, Levine LM, Levine TB. Posttraumatic stress disorder and cardiometabolic disease. Cardiology. 2014;127(1):1–19.
7. Boscarino JA. Posttraumatic stress disorder and mortality among U.S. Army veterans 30 years after military service. Ann Epidemiol. 2006;16(4):248–256.
8. Friedman MJ, Schnurr PP. The relationship between trauma, post-traumatic stress disorder, and physical health. In: Friedman MJ, Charney DS, Deutch AY, eds. NeurobiologicalandClinical ConsequencesofStress:FromNormalAdaptation toPost-TraumaticStressDisorder. Philadelphia, PA: Lippincott Williams & Wilkins Publishers; 1995:507–524.
9. Kang HK, Bullman TA, Taylor JW. Risk of selected cardiovascular diseases and posttraumatic stress disorder among former World War II prisoners of war. Ann Epidemiol. 2006;16(5):381–386.
10. Page WF, Brass LM. Long-term heart disease and stroke mortality among former American prisoners of war of World War II and the Korean Conflict: results of a 50-year follow-up. MilMed. 2001;166(9):803–808.
11. Page WF, Ostfeld AM. Malnutrition and subsequent ischemic heart disease in former prisoners of war of World War II and the Korean conflict. JClinEpidemiol. 1994;47(12):1437–1441.
12. Solomon Z. A 3-year prospective study of posttraumatic stress disorder in Israeli combat veterans. JTraumaStress. 1989;2(1):59–73.
13. Solomon Z, Greene T, Ein-Dor T, et al. The long-term implications of war captivity for mortality and health. JBehavMed. 2014;37(5):849–859.
14. Engdahl BE, Speed N, Eberly RE, et al. Comorbidity of psychiatric disorders and personality profiles of American World War II prisoners of war. JNervMentDis. 1991;179(4):181–187.
15. Ginzburg K, Ein-Dor T, Solomon Z. Comorbidity of posttraumatic stress disorder, anxiety and depression: a 20-year longitudinal study of war veterans. J Affect Disord. 2010;123(1–3):249–257.
16. Solomon Z, Bleich A. Comorbidity of posttraumatic stress disorder and depression in Israeli veterans. CNSSpectr. 1998;3(S2):15–21.
17. Dedert EA, Calhoun PS, Watkins LL, et al. Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence. Ann Behav Med. 2010;39(1):61–78.
18. Pacella ML, Hruska B, Delahanty DL. The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. JAnxietyDisord. 2013;27(1):33–46.
19. Rohleder N, Wolf JM, Wolf OT. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. NeurosciBiobehavRev. 2010;35(1):104–114.
20. Boscarino JA. A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: implications for surveillance and prevention. Psychosom Med. 2008;70(6):668–676.
21. Jordan HT, Miller-Archie SA, Cone JE, et al. Heart disease among adults exposed to the September 11, 2001 World Trade Center disaster: results from the World Trade Center Health Registry. Prev Med. 2011;53(6):370–376.
22. Vaccarino V, Goldberg J, Rooks C, et al. Posttraumatic stress disorder and incidence of coronary heart disease: a twin study. JAmColl Cardiol. 2013;62(11):970–978.
23. Friedman MJ, McEwen BS. Posttraumatic stress disorder, allostatic load, and medical illness. In: Schnurr PP, Green BL, eds. TraumaandHealth: PhysicalHealthConsequencesofExposureto ExtremeStress. Washington, DC: American Psychological Association; 2004:157–188.
24. Pace TW, Heim CM. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav Immun. 2011;25(1):6–13.
25. Schnurr PP, Jankowski MK. Physical health and post-traumatic stress disorder: review and synthesis. Semin Clin Neuropsychiatry. 1999;4(4):295–304.
26. Boscarino JA. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. AnnNYAcadSci. 2004;1032(1):141–153.
27. Farr OM, Ko B-J, Joung KE, et al. Posttraumatic stress disorder, alone or additively with early life adversity, is associated with obesity and cardiometabolic risk. NutrMetabCardiovascDis. 2015;25(5):479–488.
28. Lagraauw HM, Kuiper J, Bot I. Acute and chronic psychological stress as risk factors for cardiovascular disease: insights gained from epidemiological, clinical and experimental studies. Brain Behav Immun. 2015;50:18–30.
29. Day C. Metabolic syndrome, or what you will: definitions and epidemiology. DiabVascDis Res. 2007;4(1):32–38.
30. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. AmJMed. 2006;119(10):812–819.
31. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. JAmColl Cardiol. 2007;49(4):403–414.
32. Heath NM, Chesney SA, Gerhart JI, et al. Interpersonal violence, PTSD, and inflammation: potential psychogenic pathways to higher C-reactive protein levels. Cytokine. 2013;63(2):172–178.
33. Lindqvist D, Wolkowitz OM, Mellon S, et al. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain Behav Immun. 2014;42:81–88.
34. Miller RJ, Sutherland AG, Hutchison JD, et al. C-reactive protein and interleukin 6 receptor in post-traumatic stress disorder: a pilot study. Cytokine. 2001;13(4):253–255.
35. Spitzer C, Barnow S, Völzke H, et al. Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. JPsychiatrRes. 2010;44(1):15–21.
36. McCanlies EC, Araia SK, Joseph PN, et al. C-reactive protein, interleukin-6, and posttraumatic stress disorder symptomology in urban police officers. Cytokine. 2011;55(1):74–78.
37. von Känel R, Hepp U, Kraemer B, et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. JPsychiatrRes. 2007;41(9):744–752.
38. Söndergaard HP, Hansson L-O, Theorell T. The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clin Chim Acta. 2004;342(1–2):93–98.
39. Spitzer C, Wibisono D, Terfehr K, et al. C-reactive protein, pre- and postdexamethasone cortisol levels in posttraumatic stress disorder. NordJPsychiatry. 2014;68(5):296–299.
40. Michopoulos V, Rothbaum AO, Jovanovic T, et al. Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. AmJPsychiatry. 2015;172(4):353–362.
41. Eraly SA, Nievergelt CM, Maihofer AX, et al; Marine Resiliency Study Team. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry. 2014;71(4):423–431.
42. Rasmusson AM, Schnurr PP, Zukowska Z, et al. Adaptation to extreme stress: post-traumatic stress disorder, neuropeptide Y and metaboli syndrome. ExpBiolMed(Maywood). 2010;235(10):1150–1162.
43. Heppner PS, Crawford EF, Haji UA, et al. The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMCMed. 2009;7(1):1.
44. Bonanno GA, Mancini AD. Beyond resilience and PTSD: Mapping the heterogeneity of responses to potential trauma. Psychol Trauma. 2012;4(1):74–83.
45. Baumeister D, Akhtar R, Ciufolini S, et al. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. MolPsychiatry. 2016;21(5):642–649.
46. Coelho R, Viola TW, Walss-Bass C, et al. Childhood maltreatment and inflammatory markers: a systematic review. Acta Psychiatr Scand. 2014;129(3):180–192.
47. Safran N. Trial by Ordeal: The Yom Kippur War, October 1973. IntSecur. 1977;2(2):133–170.
48. Dekel S, Ein-Dor T, Solomon Z. Posttraumatic growth and posttraumatic distress: a longitudinal study. PsycholTrauma. 2012;4(1):94–101.
49. Solomon Z, Horesh D, Ein-Dor T, et al. Predictors of PTSD trajectories following captivity: a 35-year longitudinal study. Psychiatry Res. 2012;199(3):188–194.
50. Derogatis LR. The SCL-90 Manual I: Scoring, Administration and Procedures for the SCL-90. Baltimore: Johns Hopkins University School of Medicine, Clinical Psychometrics Unit; 1977.
51. Solomon Z, Benbenishty R, Neria Y, et al. Assessment of PTSD: validation of the revised PTSD Inventory. IsrJPsychiatryRelatSci. 1993;30(2):110–115.
52. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
53. Expert Panel on Detection ETreatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497.
54. g and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108(4):414–419.
55. Rogowski O, Vered Y, Shapira I, et al. Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation. Clin Chim Acta. 2005;358(1–2):151–158.
56. Heim C, Nemeroff CB. Neurobiology of posttraumatic stress disorder. CNSSpectr. 2009;14(suppl 1):13–24.
57. McEwen BS. Stress, adaptation, and disease: allostasis and allostatic load. AnnNYAcadSci. 1998;840(1):33–44.
58. McFarlane AC. The long-term costs of traumatic stress: intertwined physical and psychological consequences. WorldPsychiatry. 2010;9(1):3–10.
59. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986;7(3):284–301.
60. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769–1778.
61. Pradhan AD, Manson JE, Rossouw JE, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women’s Health Initiative observational study. JAMA. 2002;288(8):980–987.
62. Tuomisto K, Jousilahti P, Sundvall J, et al. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality: a population-based, prospective study. ThrombHaemost. 2006;95(3):511–518.
63. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131–2135.
64. Bierhaus A, Wolf J, Andrassy M, et al. A mechanism converting psychosocial stress into mononuclear cell activation. ProcNatlAcadSci USA. 2003;100(4):1920–1925.
65. y of poststressor rumination and distraction on cortisol and C-reactive protein. HealthPsychol. 2014;33(12):1606–1609.
66. Das SR, Kinsinger LS, Yancy WS Jr, et al. Obesity prevalence among veterans at Veterans Affairs medical facilities. AmJPrevMed. 2005;28(3):291–294.
67. Ahmadi N, Arora R, Vaidya N, et al. Posttraumatic stress disorder is associated with increased incidence of insulin resistance and metabolic syndrome. JAmCollCardiol. 2013;61(10S):E1347.
68. Heppner PS, Lohr JB, Kash TP, et al. Metabolic syndrome: relative risk associated with posttraumatic stress disorder (PTSD) severity and antipsychotic medication use. Psychosomatics. 2012;53(6):550–558.
69. Dickstein BD, Suvak M, Litz BT, et al. Heterogeneity in the course of posttraumatic stress disorder: trajectories of symptomatology. JTraumaStress. 2010;23(3):331–339.
70. O’Donnell ML, Elliott P, Lau W, et al. PTSD symptom trajectories: from early to chronic response. Behav Res Ther. 2007;45(3):601–606.
71. Andersen SB, Karstoft K-I, Bertelsen M, et al. Latent trajectories of trauma symptoms and resilience: the 3-year longitudinal prospective USPER study of Danish veterans deployed in Afghanistan. JClinPsychiatry. 2014;75(9):1001–1008.
72. Orcutt HK, Erickson DJ, Wolfe J. The course of PTSD symptoms among Gulf War veterans: a growth mixture modeling approach. JTrauma Stress. 2004;17(3):195–202.
73. Eberly RE, Engdahl BE. Prevalence of somatic and psychiatric disorders among former prisoners of war. Hosp Community Psychiatry. 1991;42(8):807–813.
74. Hunt SC, Orsborn M, Checkoway H, et al. Later life disability status following incarceration as a prisoner of war. MilMed. 2008;173(7):613–618.
75. Karstoft K-I, Armour C, Elklit A, et al. Long-term trajectories of posttraumatic stress disorder in veterans: the role of social resources. JClin Psychiatry. 2013;74(12):e1163–e1168.
76. Kershaw KN, Mezuk B, Abdou CM, et al. Socioeconomic position, health behaviors, and C-reactive protein: a moderated-mediation analysis. HealthPsychol. 2010;29(3):307–316.